IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $82,000 | +15.5% | 1,505 | +37.6% | 0.05% | +10.6% |
| Q1 2019 | $71,000 | +18.3% | 1,094 | -26.9% | 0.05% | +14.6% |
| Q4 2018 | $60,000 | -7.7% | 1,497 | -13.2% | 0.04% | +7.9% |
| Q3 2018 | $65,000 | +16.1% | 1,725 | -3.5% | 0.04% | +8.6% |
| Q2 2018 | $56,000 | +60.0% | 1,787 | +45.0% | 0.04% | +52.2% |
| Q1 2018 | $35,000 | -2.8% | 1,232 | +13.3% | 0.02% | -14.8% |
| Q4 2017 | $36,000 | – | 1,087 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |